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Background: Conservative methods for weight loss are usually disappointing. Therefore, surgeries such as
Laparoscopic Sleeve Gastrectomy (LSG) should be considered. We aimed to evaluate the outcomes (body mass
index; BMI) of LSG among obesity patients in the Northern West Bank.
Methods: Hospital records were reviewed for all patients who had undergone LSG since 2010 in Arab specialized
hospital in Nablus and Palestinian Red Crescent society hospital in Tulkarem. Then, patients have been invited again
to participate in the study and asked to self-report further pre-/post-operative measures. The primary study
outcome was the change in BMI while secondary outcomes included obesity associated co-morbidities’ measures;
hypertension (HTN) and diabetes mellitus (DM).
Results: The mean age (standard deviation; SD) of the study participants (n = 30; 20 women and 10 men) was
34.06 (10.71) years. The mean (SD) follow-up time was 7.16 (5.05) months. The mean ± SD of the pre-operative
BMI was 47.23 ± 7.89 kg/m2 while 36.74 ± 7.74 kg/m2 post-operatively (95% CI for mean differences and P-value;
8.83-12.14 and 0.001). For the clinically diagnosed hypertensive patients, there was a mean (SD) reduction of 27.50
(9.87) mm Hg in systolic pressure (P < 0.026) and 18.33 (13.66) of the diastolic blood pressure (P < 0.042). For
diabetics, there were clinically and biologically clear mean (SD) reductions in fasting blood sugar and glycated
hemoglobin A1c of about 82.00 (22.70) mg/dl and 1.90 (0.78) %; respectively. Only practicing sports or exercise
(no/yes) remained significant with post-operative BMI (regression coefficient B = −7.33; P-value and 95% CI for B;
0.009 and −12.68- -1.98).
Conclusions: LSG can significantly improve BMI and could improve or resolve obesity associated co-morbidities like
HTN and DM. LSG could be recommended for co-morbid obesity patients who fail to reach beneficial results from
a structured weight loss programs.Background
Overweight and obesity are major public health problems.
A person with a body mass index (BMI) ≥ 25 is considered
as overweight while a person with a BMI of ≥ 30 is gener-
ally considered as obese [1]. In the past few decades, the
incidence of obesity has raised dramatically in low and
middle income countries, particularly in urban setting [1].
This emerges an increase in the incidence of diseases that* Correspondence: halzabadi@gmail.com
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reproduction in any medium, provided the orare related to obesity such as hypertension, diabetes melli-
tus and cardiovascular diseases. These types of obesity co-
morbidities have high risk of mortality and represent a
heavy economical (both direct and indirect) burden on
the patient himself from one hand and the primary health
care system on the other hand [1]. Indeed, 44% of the dia-
betes burden, 23% of the ischemic heart disease burden
and between 7% to 41% of certain cancers burdens are at-
tributable to overweight and obesity [1].
In the year 2008, nearly 1.5 billion adults aged ≥ 20 years
were overweight. Of them, approximately 200 million
male and 300 million female were obese [1]. Moreover, itral Ltd. This is an Open Access article distributed under the terms of the Creative
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leading risk for global deaths and that at least 2.8 million
adults die each year as a result of being overweight or
obese [1]. In Palestine, a study was conducted in the rural
community in Ramallah city among the adults aged 30–
65 years, the results showed that obesity and overweight
were about 58.7% in men and 71.3% in women [2]. An-
other study showed that the prevalence of obesity in urban
Palestinian population was 41% (49% and 30% for women
and men; respectively) [3].
Therapeutic interventions for the treatment of obesity
range from lifestyle and diet modifications to pharmaco-
logic and surgical therapy [4]. However, studies showed
that the non-operative interventions for sustained weight
loss usually fail to provide real benefits and are usually
insufficient and not sustainable in co-morbidity obese
patients [5,6]. Now, the most popular weight loss surgery
is the bariatric surgery. It is an operative surgery of the
stomach and/or intestines that help a person with morbid
obesity to lose weight. Of them, the laparoscopic sleeve
gastrectomy (LSG; the stomach is divided vertically to re-
duce its size to about 25%, it is not reversible and it leaves
the pylorus intact with a relatively quick performance
through a laparoscope [7]. Several studies had shown that
LSG was associated with significant weight loss, remissions
and/or improvements in obesity associated co-morbidities
(e.g., diabetes mellitus; DM and hypertension; HTN), re-
ductions in mortality and in healthcare use and costs (both
direct and indirect) [8,9].
In Palestine, which has developing surgical settings,
there is no documented study that shows the efficacy of
bariatric surgery in general and LSG in particular. This
study will therefore evaluate the post-operative out-
comes of LSG (mainly BMI, weight loss, DM and HTN)
among obesity patients with and/or without associated
co-morbidities in the Northern West Bank.
Methods
Study design, settings and population
A retrospective records review was conducted. The
study population was all patients who had undergone
LSG since the year 2010 in the Arab specialized hospital
in Nablus city and the Palestinian Red Crescent society
hospital in Tulkarem city, Palestine. Patients who had
undergone repeated bariatric surgeries of any type, preg-
nant and/or lactating women in the previous 6 months
were excluded as these conditions could have interfered
with the study outcomes.
Ethical and administrative considerations
The study was approved by the Institutional Review Board
(IRB) and the scientific research committee of An-Najah
National University-Faculty of Medicine and Health Sci-
ences. Permissions to conduct the study in both hospitalshave been obtained from the medical and administrative
managers of each hospital. Subjects were invited by phone
calls to participate in the study. Standard, written and
same explanatory information about the study were deliv-
ered to the subjects after just answering the phone call.
This information included details about aim, importance,
confidentiality and anonymity of the information with
optional/voluntary participation. Those who agreed to
participate, met the inclusion criteria, accessible and
gave their verbal consent were included in the study.
Data collection
In the first phase, patients’ phone numbers were obtained
from the hospital and were given to the researcher by the
responsible surgeons. All patients (N = 36) were invited by
phone call to participate and asked for their approval to
review their medical records. For those who were access-
ible, agreed to participate and gave their verbal consent,
their hospital medical records were reviewed. In overall,
we were able to recruit 30 subjects with a response rate of
83.3% as 3 subjects refused to participate, and other 3 sub-
jects were inaccessible and therefore were excluded from
the study. All the finally recruited subjects (n = 30) met
the study inclusion criteria.
From the medical records (first stage), the collected in-
formation included some pre-operative required infor-
mation and measures (see results). In the second stage,
participants were invited again by phone calls to partici-
pate. If agreed and gave their verbal consent again (for
ethical consideration and quality control purposes), par-
ticipants were asked to self-report some required pre-
operative (not found in the medical records like food
habits) and post-operative study measures (see results).
All those who agreed to participate in the first stage also
agreed in the second stage.
The primary study outcome was the change in the
BMI before and after LSG. The secondary study out-
comes were obesity associated co-morbidities’ measures;
HTN and DM. Briefly, the pre- and post-operative
weight, height, blood pressure for all patient were ob-
tained from medical records and patients self-report; re-
spectively. The pre- and post-operative Fasting Blood
Sugar (FBS) and Glycated Hemoglobin A1c (HbA1c)
were assessed for diabetic patient only by the similar
method (pre-operatively from medical records and post-
operatively by patients self-report). The pre-operative
measures were those taken at referral while the post-
operative were those carried out by the patients (labora-
tory documented) at the closest time before phone
interview (usually were very near to the time of phone
interviews). Changes in HTN and DM medications usage
were assessed through the medical records in the pre-
operative stage and by patient self-report at the post-
operative stage.
Table 1 Socio-demographic characteristics of the study
population (N = 30)
Variable n (%)*
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All data has been entered and analyzed using the statis-
tical software package SPSS (Statistical Package for the
Social Sciences) version 16 [10]. The main study out-
comes were tested for normality using Shapiro Wilk
significant test. For the differences between pre- and
post-operative continuous outcomes, paired samples
t-test and Wilcoxon test were used to analyze the differ-
ences between normally distributed and non-normally
distributed variables; respectively. One-way ANOVA
was used to test for the association in the mean differ-
ences of the main study outcome (post-operative BMI)
among different independent categorical variables while
linear regression to test for such an association with
continuous independent variables. Multivariate linear
regression model was developed for the main study out-
come (post-operative BMI). Variables were entered in
the model if they showed a significant P-value of <0.05
in the univariate analysis. P-value of less than 0.05 was
considered as statistically significant.-Gaza 1 (3.3)
Marital status
-Not married 10 (33.3)
-Married 20 (66.7)
Monthly family income (NIS)§
-< 2500 8 (30)
-> 2500 22 (70)
*Data is presented as frequency (percent) from the total study
population (N = 30).
**Mean ± standard deviation. §NIS: New Israel Shekel.Results
Description of the study participants
During the study period (January to March, 2012), we
were able to investigate 30 patients. The mean ± standard
deviation (SD) of the post-operative follow-up time was
7.16 ± 5.05 months. Only three patients had DM and six
had hypertension. Of the overall (30 patients), nearly equal
percentages of patients were from each hospital (47% from
Arab specialized hospital and 53% from Palestinian Red
Crescent Society hospital in Tulkarem).
As presented in Table 1, the mean age (SD) of the
study population was 34 (10.7) years. Of the 30 pa-
tients, nearly 67% (n = 20) were females. Those who
were not married (single, divorced and widow) consti-
tuted nearly 33% from the whole study population.
We merged divorced and widow patients in the “sin-
gle” category as we found small number in each (only
one case each). Almost 44% (n = 13) out of 30 pa-
tients were housewives.Distribution of the study participants by some food
intake and lifestyle habits
As presented in Table 2, nearly half (56.7%) of the study
participants reported taking more than three meals per
day before surgery. This was changed into only 30% after
surgery. The regular vegetables and fruits intakes were
increased to 40% after surgery (23.3% and 16.7% before
surgery; respectively). Before surgery, only 20% was prac-
ticing sport or exercise. However, this percentage in-
creased to 40% after surgery. Never smokers represented
50% of our study population while current smokers rep-
resented only 36.7%.Evaluation of the study outcomes
Table 3 shows the mean differences and their 95% CI
(confidence interval) for the study outcomes (weight, BMI,
systolic and diastolic blood pressure). These study out-
comes were shown to be normally-distributed (Shapiro
Wilk significant test of normality was always > 0.05). As
shown in the table, there were strong statistical-significant
mean reduction in the weight by 30.11 kg and in the BMI
by 10.50 kg/m2 (the 95%CI for the mean differences,
P-values respectively are: 26.38-33.85, < 0.001 and 8.83-
12.14, <0.001). Table 3 also shows the mean differences
between the pre-and post-operative systolic and diastolic
blood pressures where they also showed strong statistical-
significant differences (Table 3).
In this study, however, there were only three patients
with clinically diagnosed diabetes mellitus. Their pre- and
post-operative FBS and HbA1c measures are presented in
Table 4 below. The means (SDs) reductions in the FBS
and HbA1c were 82.00 ± 22.70 mg/dl and 1.90 ± 0.78%; re-
spectively (P-values = 0.109). It should also be noted that
two of those DM patients were on a once-daily dose of
850 mg metformin and after two months of operation
they totally stopped their drug. The other one was on a
Table 2 Distribution of the study participants by some
food intake and lifestyle habits before and after
(currently) the surgery (N = 30)
Variable Before n (%)* Currently n (%)*
How many main meals do you eat
per day?
-One 1 (3.3) 2 (6.7)
-Two 3 (10) 7 (23.3)
-Three 9 (30) 12 (40)
-> three 17 (56.7) 9 (30)
Vegetables intake
-Regularly 7 (23.3) 12 (40)
-Occasionally 11 (36.7) 11 (36.7)
-Rarely 12 (40) 7 (23.3)
Fruit intake
-Regularly 5 (16.7) 12 (40)
-Occasionally 12 (40) 13 (43.3)
-Rarely 13 (43.3) 5 (16.7)
How often you take fried food
per week?
-1-3 10 (33.3) 27 (90)
-4-6 13 (43.3) 1 (3.3)
-7-9 5 (16.7) 2 (6.7)
->9 2 (6.7) 0 (0)
Do you practice any kind of sport
or exercise?
-No 24(80) 18 (60)
-Yes 6 (20) 12 (40)
Smoking habits
-Never smoker - 15 (50)
-Ex-smoker - 1 (3.3)
-Current smoker - 11 (36.7)
-Argellah - 3 (10)
*Data is presented as frequency (percent) from the total study
population (N = 30).
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months of operation he decreased the dose to 1 mg
once-daily.
On the other side, there were only six patients with
clinically diagnosed hypertension. Their pre- and post-
operative blood pressures are presented in Table 4. Re-
sults showed that after LSG, the mean ± SD reduction in
their systolic and diastolic blood pressures were 27.50 ±
9.87 (P-value = 0.026) and 18.33 ± 13.66 (P-value = 0.042);
respectively.
Association between the main study outcome (BMI) and
other independent variables
As mentioned previously, the main study outcome was
post-operative BMI. For this, we have evaluated theeffect of different study independent variables on this
study outcome (dependant variable). Indeed, we used
one-way ANOVA analysis to test for the association in
the mean differences of the post-operative BMI among
different independent variables with more than two cat-
egories (including the food and lifestyles habits before
and after operation). However, simple linear regression
analysis was used to test for the association between the
post-operative BMI and the independent variables with;
(1) two categories and (2) continuous independent vari-
ables (age, post-operative time). The analysis did not
reveal any significant associations (P >0.05) except for
marital status (not-married/married; positive association),
age (positive association), and practice any kind of sport
or exercise currently (no/yes; strong negative association)
variables. Table 5, shows this simple association between
the post-operative BMI and the independent variables that
found to be significant in univariate analysis.
Figure 1 represents the relationship between the post-
operative BMI and age while Figure 2 shows the relation-
ship with the post-operative follow-up time. As shown in
Figure 1, the age was positively statistically-significant with
post-operative BMI (P = 0.033; R2 linear = 15.2%). On
the other hand, post-operative follow-up time failed to
reach a statistically-significant correlation with the post-
operative BMI (although a general negative correlation
was observed, P = 0.33; R2 linear = 3.4%; Figure 2).
Multivariate analysis for the main study outcome
(post-operative BMI)
Based on the univariate associations, we developed a
multivariate linear regression model for the post-operative
BMI outcome variable. Variables entered in the model if
they showed significant P-value of less than 0.05 in univar-
iate analysis. Table 6, however, represents the multivariate
linear regression model for the post-operative BMI. Only
practicing any kind of sport or exercise currently (after
surgery) remained significant (i.e., not practicing sport or
exercise currently were more likely to have higher BMI
index compared to those practicing sport or exercise).
Furthermore, this negative association was represented in
Table 5 also where the one-way ANOVA showed that the
post-operative BMI mean (SD) among those who did not
report practicing sport or exercise was 40.3 (7.3) kg/m2
while it was 31.4 (4.8) kg/m2 among those practicing sport
or exercise.
Discussion
To our knowledge, this is the first study in Palestine that
evaluates the outcomes of LSG. The main study findings
were that LSG showed remarkable success in both reducing
BMI (main study outcome) and obesity related complica-
tions. Clearly, the study showed that there was a strong
statistically significant reduction in the mean of the BMI
Table 3 The mean ± SD for the pre- and post-operative measurements of the study outcomes and their paired samples
t-test (N = 30)
Variable Mean ± SD* Mean difference ± SD 95% CI of the difference** P value
Weight (Kg)
- Pre-operative 134.68 ± 27.17
- Post-operative 104.50 ± 26.95 30.11 ± 10.01 26.38-33.85 < 0.001
Height (meter)
- Pre-operative 1.68 ± 0.107
- Post-operative 1.68 ± 0.107 0 - -
BMI (kg/m2)
- Pre-operative 47.23 ± 7.89
- Post-operative 36.74 ± 7.74 10.49 ± 4.43 8.83-12.14 < 0.001
Systole (mg Hg)
- Pre-operative 131.13 ± 16.84
- Post-operative 117.83 ± 7.39 13.33 ± 16.66 7.07-19.52 < 0.001
Diastole (mg Hg)
- Pre-operative 84.73 ± 11.90
- Post-operative 75.83 ± 7.88 8.90 ± 12.84 4.10-13.69 < 0.001
*SD: Standard deviation. **95% CI: 95% confidence interval of the mean difference; BMI: Body mass index.
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36.74 ± 7.74 kg/m2 post-operatively (95% CI for the mean
difference and P-value; 8.83-12.14 kg/m2 and <0.001). Re-
garding weight alone, there was also a statistically signifi-
cant reduction in the mean ± SD from 134.68 ± 27.17 pre-
operatively to104.50 ± 26.95 kg post-operatively (95% CI for
the mean difference and P-value; 26.38-33.85 kg and
<0.001; Table 3). These results were found after a mean
follow up (post-operative time) of nearly 7.2 months
(SD = 5 months). LSG could therefore be considered asTable 4 Pre- and post-operative measurements for the diabet
(n = 6)
Variable Mean ± SD* Range**
Diabetes mellitus patients (n = 3)
FBS (mg/dl)
- Pre-operative 172.32 ± 25.42 50 (200–1
- Post-operative 90.33 ± 17.03 30 (110–8
HbA1c (%)
- Pre-operative 6.76 ± 1.11 2.10 (7.60
- Post-operative 4.86 ± 1.17 2.20 (6.20
Hypertensive patients (n = 6)
Systole (mm Hg)
- Pre-operative 146.67 ± 5.16 10 (150–1
- Post-operative 119.17 ± 11.14 30 (140–1
Diastole (mm Hg)
- Pre-operative 95.00 ±5.47 10 (100–9
- Post-operative 76.66 ± 9.83 25 (90–65
*SD, standard deviation; FBS, fasting blood sugar; mg/dl, milligram/deciliter; HbA1c,a significant intervention for decreasing both BMI and
weight in adults. These results were in accordance with
previous studies. One study for example, showed a sig-
nificant reduction in the mean of BMI from 37.4 ± 6.2 to
30.1 ± 5.9 kg/m2 after 6 months [11]. Another study was
performed among morbidly obese patient underwent
LSG. The findings showed that patients who underwent
LSG had a significant mean weight ± SD decrease from
161.42 ± 34.3 to 112.91 ± 25.55 kg (p < 0.01) where the
mean ± SD of BMI was decreased from 57.5 ± 9.55 toes mellitus patients (n = 3) and the hypertensive patients
Mean difference ± SD P value§
50)
0) 82.00 ± 22.70 0.109
-5.50)
-4) 1.90 ± 0.78 0.109
40)
10) 27.50 ± 9.87 0.026
0)
) 18.33 ± 13.66 0.042
glycated hemoglobin. **Range (Maximum-Minimum).§P-value of Wilcoxon test.
Table 5 The simple associations between the main study
outcome (post-operative BMI) and marital status, practice
of sport or exercise currently and age variables (N = 30)§
Post-operative BMI
Independent variables B SE Beta P-value (95% CI for B)
Age (years) 0.28 0.13 0.39 0.033 (0.02-0.54)*
Marital status
(not married/married)
6.88 2.76 0.43 0.019 (1.22-12.54)*
Practice any kind of sport or
exercise currently (no/yes)
−8.89 2.41 −0.57 0.001 (−13.83- -3.95)*
§Simple linear regression was used. SE, standard error; B, Unstandardized
regression coefficient; Beta, Standardized regression coefficient; CI, confidence
interval; BMI, body mass index.*Statistically significant (p <0.05).
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Another study in India showed that patients’ body weight
decreased significantly from a pre-operative of 131.2 ±
21.6 kg (mean ± SD) to a post-operative of 99.4 ± 16.6 kg
with a BMI decrease from 47.0 ± 7.9 to 34.7 ± 5.8 kg/m2
(mean ± SD) [12].
In general, studies showed that significant improvement
or remission of diabetic markers was commonly observed
after bariatric surgery and improvement of co-morbid con-
ditions after LSG [13]. In our study we found a mean de-
crease of FBS and HbA1c among the three DM patients of
82 mg/dl and 1.9% respectively. Wilcoxon test analysis for
the pre- and post-operative measures of those patients did
not showed statistical significant differences (P = 0.109)Figure 1 The relationship between the post-operative BMI (main stud
line with 95% confidence intervals of the mean are shown. BMI, body masseventually due to small sample size (n = 3) although there
were clinically and biologically clear reductions in both
measures (Table 4). Moreover, two DM patients in our
study stop their medications after two months of the LSG
while one DM patients decrease the dose to one-third.
More recently in 2010, LSG and type 2 diabetes mellitus
(T2DM) were studied in a review and included all studies
from 2000 to 2010. In overall, they found that DM had re-
solved in 66.2% of the patients, improved in 26.9%, and
remained stable in 13.1%. The mean decrease in FBS and
hemoglobin HbA1c levels after LSG was 88.2 mg/dl and
1.7%, respectively [14]. We have reported nearly the same
results among the Palestinian population of the Northern
West Bank.
Regarding the blood pressure outcome, in our study
there were general reductions among all participants’
systolic and diastolic blood pressure. As expected, there
was a benefit from LSG regarding blood pressure. Indeed,
we found a significant mean reduction in both systolic
and diastolic blood pressure for the whole study popula-
tion (n = 30) of about 13.33 and 8.90 mg Hg; respectively
(Table 3). In our study however, we had only 6 clinically
diagnosed hypertensive patients. After LSG, there was a
significant mean ± SD reduction in their systolic and dia-
stolic blood pressures of 27.50 ± 9.87 mg Hg (P-value <
0.026) and 18.33 ± 13.66 mg Hg (P-value <0.042); respect-
ively (Table 4). These findings indicate that the benefit
from LSG regarding blood pressure is more significant fory outcome) and the participants’ age. Scatter-plot and regression
index [(weight (kilogram) divided by the square of height (meter)].
Figure 2 The relationship between the post-operative BMI (main study outcome) and the participants’ post-operative follow-up time.
Scatter-plot and regression line with 95% confidence intervals of the mean are shown. BMI, body mass index [(weight (kilogram) divided by the
square of height (meter)].
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no previous study that specifically measured the mean re-
duction in systolic and diastolic blood pressures for hyper-
tensive patient underwent LSG. However, after one year of
follow-up, a study described the changes in the blood
pressure for all participants underwent LSG. It concluded
that LSG was effective for reduction of cardiovascular risk
in severely obese patients at one year of follow-up. The
systolic blood pressure decreased from 128.5 ± 12.9 to
113.4 ± 13.1 mg Hg (mean ± SD), whereas diastolic boold
pressure decreased from 81.8. ± 9.5 to 71.9 ± 8.0 mg HgTable 6 Multivariate linear regression model for the
association of the main study outcome (post-operative
BMI) with marital status, practice of sport or exercise and
age variables (N = 30)§
Post-operative BMI
Independent variables B SE Beta P-value (95% CI for B)
Age (years) 0.17 0.12 0.23 0.18 (−0.83-0.42)
Marital status (not
married/married)
1.84 2.97 0.11 0.54 (−4.28-7.95)
Practice any kind of sport
or exercise currently (no/yes)
−7.33 2.60 −0.47 0.009 (−12.68- -1.98)*
§Variables entered in the model are those with a P- value <0.05 in univariate
analysis. SE, standard error; B, Unstandardized regression coefficient; Beta,
Standardized regression coefficient; CI, confidence interval; BMI, body mass
index [(weight (kilogram) divided by the square of height (meter)].
*Statistically significant (p <0.05). Enter regression method was used.(mean ± SD) for all patients who underwent LSG (40 par-
ticipant) [15]. Our results were nearly approximating the
above study findings which suggest that LSG is found
again to be effective among the Palestinian population in
reducing their general blood pressure. This is supported
by the finding that 4 (66%) out of our 6 hypertensive pa-
tients showed improvement in their blood pressure after
LSG as indicated by frequency of medication usage.
One retrospective study, for example, reviewed 130 pa-
tients who underwent LSG from January 2003 to May
2004 and aimed to evaluate the results of LSG at one
year in morbidly obese Korean patients. The results
showed that HTN was resolved in 92.9% and improved in
100% of patients [16]. Another study was conducted in
2008 and reviewed data for 100 patients who underwent
LSG at Counties Manukau District showed that, with
mean age 43 years, 60% of patient who had hypertension
pre-operatively (n = 45) resolved after one year post-
operatively [17]. It should be noted however that, the
small number of diabetic and hypertensive patients in our
study could be due to the small sample size from one
hand and to the relatively young mean (SD) age of about
34 (10.7) for our participants from the other hand.
As mentioned previously, the main study outcome was
post-operative BMI. For this, we have evaluated the effect
of different study independent variables on this study
outcome (dependant variable). Although the association
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and the post-operative time (Figure 2) failed to reach a sta-
tistically significant result (P = 0.33), a negative association
was observed with an R2 linear of about 3.4%. We did not
find a study that correlated the post-operative BMI with
the post-operative follow-up time. However, our finding
could be explained by that as long as the time pass after
LSG surgery, the benefit is increased through the decrease
in the post-operative BMI [18].
The other univariate one-way ANOVA and simple lin-
ear regression analyses did not reveal any significant asso-
ciations (P >0.05) except for marital status (not-married/
married), age (continuous) which individually showed a
positive association (P <0.05, Table 5 and Figure 1) and
practicing any kind of sport or exercise after surgery (no/
yes) that in turn showed a strong negative association
(P <0.05). In multivariate linear regression analysis, only
practicing any kind of sport or exercise after surgery
(no/yes) remained statistically significant predictor of
post-operative BMI with negative association (95% CI for
B and the P-value are; -12.68- -1.98 and 0.009; i.e., not
practicing sport or exercise after surgery was more likely
to be associated with higher BMI index compared to those
practicing sport or exercise). The explanation of these
multivariate results of practicing exercise and/or sport can
be explained by the effect of physical activity on consum-
ing calories and decreasing the weight in general. For
those with BMI of more than 40, some studies showed
that BMI did not show significant changes with the guided
physical activity program (lasted 3 months with 5-weekly
sessions of about 45 minutes each) unless accompanied by
dietary restriction [19]. This could explain why increasing
physical activity after LSG in our study was associated
with a decrease in the post-operative BMI as LSG eventu-
ally works by decreasing the size of the stomach and thus
the amount of food intake.
Despite the great efforts we exerted to include more
participants in our study, this study was mainly limited
by the small sample size (n = 30) and nearly the short
post-operative follow-up time (mean = 7 months) due to
limited resources and time. This might have limited the
analysis of some variables in our study as well as the
generalization of our results. Therefore, further larger
and long-term studies are needed to evaluate the efficacy
of LSG in adults and to generate the results of this
study. Another limitation of our study is that some of
our pre-and post-operative measures were self-reported
by the patients. This could have resulted in the recall
bias where an over-and/or under-estimation could have
been occurred and therefore affected some of our vari-
ables mainly when reporting food intake and lifestyles
habits from the study questionnaire. However, other vari-
ables like socio-demographic, FBS, Hb1Ac, weight, height,
post-operative time, systolic and diastolic blood pressurescould not have been misestimated as those participants
represents an informative group of patients who had
undergone a major and recommended surgical operation
for a strong purpose and motivation. It represents for
them an important intervention to control their BMI.
Therefore we belief that they know very well their per-
sonal measurements related to this operation and are on a
continuous self-monitoring and observation to their phys-
ical changes and co-morbidities. In the meanwhile, the pa-
tients reported their FBS and the Hb1Ac from the closest
documented laboratory test performed prior to phone
interview. We have nearly equal number of participants
from both hospitals; therefore the effect of the operation
setting is expected to be minimal.
Conclusions
LSG can significantly improve the BMI. It may also im-
prove and/or resolve obesity associated co-morbidities
like blood pressures and DM. We suggest that, LSG is
an effective option in obese adults resulting in a signifi-
cant weight loss. It could be recommended as a useful
and single intervention therapy for co-morbid obesity
patients who usually fail to reach and provide real bene-
fits from a structured weight loss programs.
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